Mineralys Therapeutics, Inc. ($MLYS)
Filing Information
| Accession Number | 0001672659-26-000020 |
|---|---|
| Form Type | 4 |
| Filing Date | Apr 14, 2026 |
| Document | View SEC Filing |
Transactions
3
Total Shares
6,510
Total Value
$94,134.60
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Medical Officer | Common Stock | โ | Apr 9, 2026 | Exercise/Conversion | 2,170 | $16.00 | $34,720.00 | 78,310 | Direct | โ | View Details | |
Chief Medical Officer | Common Stock | โ | Apr 9, 2026 | Sale | 2,170 | $27.38 | $59,414.60 | 76,140 | Direct | โ | View Details | |
Chief Medical Officer | Stock Option | Derivative | Apr 9, 2026 | Exercise/Conversion | 2,170 | $0.00 | $0.00 | 21,706 | Direct | โ | View Details |